Matches in SemOpenAlex for { <https://semopenalex.org/work/W145417760> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W145417760 abstract "Cyclin G2 (G2) is a stress response protein with intrinsic growth inhibitory activity. G2 expression is induced by DNA damage and other stresses, but inhibited by activation of the PI3K pathway. Treatment of HER2 + breast cancer cells with Herceptin® (blocks HER2 receptor mediated PI3K activation) or with the PI3K inhibitor (Ly294002), potently elevates G2 levels. Ectopic G2 expression results in a p53-dependent cell cycle arrest, although the mechanism is unknown. Cyclin G2 is a centrosomal and nucleo-cytoplasmic shuttling protein. We hypothesize that dysregulation of G2 expression, interactions, or subcellular localization leads to a loss of proper cell cycle control. We examined whether elevation of G2 is necessary for the growth inhibitory effects induced by anti-cancer agents. Here, we show that Adriamycin® (Adr) potently upregulates G2. We treated cells with Adr in the presence of G2-specific shRNAs and remarkably, depletion of endogenous G2 abrogates the Adr-induced G2-phase cell cycle arrest. Moreover, overexpression of G2 promotes the activation of the DNA damage response kinase, Chk2, and the cell cycle arrest induced by ectopic G2 requires Chk2. Combined Herceptin® plus Adriamycin® therapy improves survival rates and reduces the risks of breast cancer recurrence in premenopausal women. As these anti-cancer agents upregulate G2 and G2 exhibits growth inhibitory activity, understanding how G2 modulates checkpoint responses is highly warranted. Supported by NIH R01 GM56900 & DOD BCRP BC045656." @default.
- W145417760 created "2016-06-24" @default.
- W145417760 creator A5045129213 @default.
- W145417760 creator A5047049412 @default.
- W145417760 creator A5071886776 @default.
- W145417760 creator A5076631400 @default.
- W145417760 date "2006-03-01" @default.
- W145417760 modified "2023-09-23" @default.
- W145417760 title "A Potent G2‐Phase Checkpoint Response to Adriamycin‐Induced DNA Damage Requires Cyclin G2 Upregulation" @default.
- W145417760 doi "https://doi.org/10.1096/fasebj.20.5.lb49-a" @default.
- W145417760 hasPublicationYear "2006" @default.
- W145417760 type Work @default.
- W145417760 sameAs 145417760 @default.
- W145417760 citedByCount "0" @default.
- W145417760 crossrefType "journal-article" @default.
- W145417760 hasAuthorship W145417760A5045129213 @default.
- W145417760 hasAuthorship W145417760A5047049412 @default.
- W145417760 hasAuthorship W145417760A5071886776 @default.
- W145417760 hasAuthorship W145417760A5076631400 @default.
- W145417760 hasConcept C104317684 @default.
- W145417760 hasConcept C105696609 @default.
- W145417760 hasConcept C120089663 @default.
- W145417760 hasConcept C120504264 @default.
- W145417760 hasConcept C127561419 @default.
- W145417760 hasConcept C143425029 @default.
- W145417760 hasConcept C1491633281 @default.
- W145417760 hasConcept C185592680 @default.
- W145417760 hasConcept C199835354 @default.
- W145417760 hasConcept C2776912716 @default.
- W145417760 hasConcept C2778437423 @default.
- W145417760 hasConcept C29537977 @default.
- W145417760 hasConcept C50001416 @default.
- W145417760 hasConcept C502942594 @default.
- W145417760 hasConcept C54086632 @default.
- W145417760 hasConcept C54355233 @default.
- W145417760 hasConcept C552990157 @default.
- W145417760 hasConcept C55493867 @default.
- W145417760 hasConcept C62478195 @default.
- W145417760 hasConcept C81885089 @default.
- W145417760 hasConcept C86554907 @default.
- W145417760 hasConcept C86803240 @default.
- W145417760 hasConcept C95444343 @default.
- W145417760 hasConcept C97037327 @default.
- W145417760 hasConceptScore W145417760C104317684 @default.
- W145417760 hasConceptScore W145417760C105696609 @default.
- W145417760 hasConceptScore W145417760C120089663 @default.
- W145417760 hasConceptScore W145417760C120504264 @default.
- W145417760 hasConceptScore W145417760C127561419 @default.
- W145417760 hasConceptScore W145417760C143425029 @default.
- W145417760 hasConceptScore W145417760C1491633281 @default.
- W145417760 hasConceptScore W145417760C185592680 @default.
- W145417760 hasConceptScore W145417760C199835354 @default.
- W145417760 hasConceptScore W145417760C2776912716 @default.
- W145417760 hasConceptScore W145417760C2778437423 @default.
- W145417760 hasConceptScore W145417760C29537977 @default.
- W145417760 hasConceptScore W145417760C50001416 @default.
- W145417760 hasConceptScore W145417760C502942594 @default.
- W145417760 hasConceptScore W145417760C54086632 @default.
- W145417760 hasConceptScore W145417760C54355233 @default.
- W145417760 hasConceptScore W145417760C552990157 @default.
- W145417760 hasConceptScore W145417760C55493867 @default.
- W145417760 hasConceptScore W145417760C62478195 @default.
- W145417760 hasConceptScore W145417760C81885089 @default.
- W145417760 hasConceptScore W145417760C86554907 @default.
- W145417760 hasConceptScore W145417760C86803240 @default.
- W145417760 hasConceptScore W145417760C95444343 @default.
- W145417760 hasConceptScore W145417760C97037327 @default.
- W145417760 hasFunder F4320306078 @default.
- W145417760 hasFunder F4320332161 @default.
- W145417760 hasIssue "5" @default.
- W145417760 hasLocation W1454177601 @default.
- W145417760 hasOpenAccess W145417760 @default.
- W145417760 hasPrimaryLocation W1454177601 @default.
- W145417760 hasRelatedWork W2001987423 @default.
- W145417760 hasRelatedWork W2007821552 @default.
- W145417760 hasRelatedWork W2029191005 @default.
- W145417760 hasRelatedWork W2040329793 @default.
- W145417760 hasRelatedWork W2142823539 @default.
- W145417760 hasRelatedWork W2188613639 @default.
- W145417760 hasRelatedWork W2408878688 @default.
- W145417760 hasRelatedWork W2602252491 @default.
- W145417760 hasRelatedWork W2968610575 @default.
- W145417760 hasRelatedWork W4221034800 @default.
- W145417760 hasVolume "20" @default.
- W145417760 isParatext "false" @default.
- W145417760 isRetracted "false" @default.
- W145417760 magId "145417760" @default.
- W145417760 workType "article" @default.